ClinicalTrials.Veeva

Menu

Transcranial Direct Current Stimulation to Treat Major Depressive Disorder

U

University of Sao Paulo

Status and phase

Completed
Phase 3
Phase 2

Conditions

Major Depressive Disorder

Treatments

Procedure: transcranial direct current stimulation

Study type

Interventional

Funder types

Other

Identifiers

NCT01149889
USP-HU-002

Details and patient eligibility

About

The investigators purpose is to offer active Transcranial Direct Current Stimulation (tDCS) in patients of the investigators previous study who received either placebo or sertraline and have not responded.

Enrollment

60 patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Patients from a previous study (ID:USP-HU-001) who:

  • received sertraline and did not respond.
  • received placebo and did not respond.

Exclusion criteria

Patients from a previous study who:

  • received active tDCS.
  • responded.

Trial design

60 participants in 1 patient group

active stimulation
Experimental group
Description:
In active stimulation, the anode is placed over the left dorsolateral prefrontal cortex and the cathode is placed over the right prefrontal cortex. They are located five centimeters ventrally of the primary motor area, which are located five centimeters laterally of the central point of the scalp (which is located on the intersection of the sagittal and median curves). The device will deliver a charge of 2mA for 30 minutes.
Treatment:
Procedure: transcranial direct current stimulation

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems